Starr HL, Abell J, Larish A, Lewis S, DeMuro C, Gogate J, Jamieson C, Daly E, Zaki N, Kramer M. Self-reported review of the value of esketamine in patients with treatment-resistant depression: understanding the patient experience in the STRIVE Study. Psychiatry Research. 2020 Nov;293:113376. doi: 10.1016/j.psychres.2020.113376
Mansfield C, Sutphin J, Boeri M. Assessing the impact of excluded attributes on choice in a discrete choice experiment using a follow-up question. Health Econ. 2020 Oct;29(10):1307-15. doi: 10.1002/hec.4124
Chapman L, Richardson S, McLeod L, Rimm E, Cohen J. Pilot evaluation of aggregate plate waste as a measure of students' school lunch consumption. Presented at the 2019 Annual Meeting of the American Society for Nutrition; June 9, 2019. Baltimore, MD. [abstract] Curr Dev Nutr. 2019 Jun 13; 3(Suppl 1):1391-2.
Webb J, Saande CJ, Schalinske K, Rowling M. Whole egg consumption in Zucker diabetic fatty rats display a dose-dependent reduction in weight gain and total body fat, accompanied by an increase in lean body mass. Curr Dev Nutr. 2019 Jun 13;3(Suppl 1):P21-054-1. doi: 10.1093/cdn/nzz041.P21-054-19
Saande CJ, Steffes MA, Webb JL, Valentine RJ, Rowling MJ, Schalinske KL. Whole egg consumption impairs insulin sensitivity in a rat model of obesity and type 2 diabetes. Curr Dev Nutr. 2019 Mar 11;3(4):nzz015. doi: 10.1093/cdn/nzz015
Saande CJ, Coonts C, Reed CH, Hahn KE, Rowling MJ, Schalinske K. Consumption of dietary whole egg reduces cumulative body weight gain in diet-induced obese rats. Curr Dev Nutr. 2018 Nov;2(11):P23-092. doi: 10.1093/cdn/nzy050
Kohlmeier M, Dong O. CKM genetic variants and muscle vulnerability to low magnesium intake. Presented at the 2018 American Society for Nutrition Annual Meeting; June 11, 2018. Boston, MA. [abstract] Curr Dev Nutr. 2018 Jun 28; 2(11). doi: 10.1093/cdn/nzy044
Heidenreich S, Watson V, Ryan M, Phimister E. Decision heuristic or preference? Attribute non-attendance in discrete choice problems. Health Econ. 2018 Jan;27(1):157-71. doi: 10.1002/hec.3524
Dong OM, Suzuki O, Howard R, Jamieson K, Pointer M, Kohlmeier M, Wiltshire T. Characterizing the genetics of salt sensitivity: a cost-efficient assay in development. Poster presented at the 2018 American Society for Nutrition Annual Meeting; June 10, 2018. Boston, MA. [abstract] Curr Dev Nutr. 2018; 2(11).
Tsuchiya A, Watson V. Re-thinking “the different perspectives that can be used when eliciting preferences in health". Health Econ. 2017 Dec;26(12):e103-7. doi: 10.1002/hec.3480
Krucien N, Watson V, Ryan M. Is best-worst scaling suitable for health state valuation? A comparison with discrete choice experiments. Health Econ. 2017 Dec;26(12):e1-e16. doi: 10.1002/hec.3459
Wollschlaeger BA, Willson TM, Montejano LB, Ronquest NA, Nadipelli VR. Characteristics and treatment patterns of US commercially insured and Medicaid patients with opioid dependence or abuse. J Opioid Manag. 2017 Jul;13(4):207-20. doi: 10.5055/jom.2017.0389
Watson V, Becker F, de Bekker-Grob E. Discrete choice experiment response rates: a meta-analysis. Health Econ. 2017 Jun;26(6):810-7. doi: 10.1002/hec.3354
Ronquest N, Wollschlaeger B, Montejano L, Wilson T, Nadipelli V. Characteristics and treatment patterns of US medicaid patients with opioid use disorder. Poster presented at the 2016 International Conference on Opioids Conference; June 2016. Boston, MA. [abstract] J Opioid Manag. 2016 May; 12(3):227.
Saigi N, Espelt A, Folch C, Sarasa-Renedo A, Castellano Y, Majo X, Merono M, Brugal MT, Casabona J, REDAN Group. Differences in illegal drug consumption between native and immigrants in a large sample of injected drug users in Catalonia (Spain). Adicciones. 2014;26(1):69-76. doi: 10.20882/adicciones.136
Zarkin GA, Cowell AJ, Hicks KA, Mills MJ, Belenko S, Dunlap LJ, Houser KA, Keyes V. Benefits and costs of substance abuse treatment programs for state prison inmates: results from a lifetime simulation model. Health Econ. 2012 Jun;21(6):633-52.
Hong J, Reed C, Novick D, Haro JM, Aguado J. Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study. Psychiatry Research. 2011 Nov 30;190(1):110-4.
Hauber AB, Fleischmann J, Lothgren M, Wilson M, Lam A, Dubois D, Sabatowski R. Economic evaluation of OROS hydromorphone for chronic pain: a Pan-European perspective. J Opioid Manag. 2011 Jul 1;7(4):287-96.
Zarkin GA, Dunlap LJ, Hicks KA, Mamo D. Benefits and costs of methadone treatment: results from a lifetime simulation model. Health Econ. 2005 Nov 1;14(11):1133-50.